DHL healthcare logistics expands with new Pennsylvania hub
Subscribe to our free newsletter today to keep up to date with the latest supply chain industry news.
DHL Supply Chain is dramatically expanding its presence in US healthcare logistics with a new distribution center of more than 1 million square feet in Annville, Pennsylvania, designed to move pharmaceuticals and medical products faster and more reliably across the East Coast.
The facility, scheduled to open later this year, sits near major highways and includes advanced temperature‑controlled space for sensitive medicines, sustainability features such as solar power systems and electric vehicle charging stations, and extensive parking and dock capacity. Once operational, the site will also operate as a Foreign Trade Zone, which can help accelerate customs processing and reduce delays tied to tariffs and regulatory complexity.
“As pharmaceutical companies navigate tariff changes, rising demand for temperature‑controlled infrastructure, and strict regulatory compliance, they need logistics partners with proven expertise,” said Mark Kunar, CEO of DHL Supply Chain North America. He called the Annville site a “critical next step” in how DHL supports the healthcare industry.
A hub built for healthcare and life sciences
The new Pennsylvania center reflects DHL’s strategic focus on life sciences and healthcare logistics as high growth segments within its global portfolio. The site is engineered to support a mix of regulated product flows, including cold chain environments that meet US Food and Drug Administration and good manufacturing practice standards.
Positioned near Interstate Highways 76 and 81 in central Pennsylvania, the facility offers multimodal access to one of the country’s densest clusters of hospitals, specialty manufacturers and research facilities. Its design includes space for more than 100 dock doors, hundreds of trailer parking spots, and employee parking, making it a key node in DHL’s East Coast logistics footprint.
By operating as a Foreign Trade Zone, the site will provide eligible companies with expedited customs processing and potential tariff advantages, an important benefit for medical technology and pharmaceutical manufacturers and distributors facing complex US import rules.
Growing final‑mile and specialty delivery
The Annville facility complements DHL’s recent acquisition of SDS Rx, a US delivery company with more than 200 local branches focused on healthcare and final‑mile delivery. Under DHL’s ownership, SDS Rx expands the company’s ability to serve specialty pharmacies, long‑term care facilities and hospital systems with precision delivery services tailored to regulated products.
“Final‑mile delivery is a critical component of the healthcare logistics ecosystem,” Kunar said after the acquisition closed. “With SDS Rx now part of our network, we are well positioned to serve health systems, care centers and patients with precision, speed, and care.”
This expanded delivery reach is especially important as demand continues to grow for specialty drugs, biologics and other medically sensitive products that require exact timing and strict temperature control during transport.
Strategic context and market demand
The broader life sciences logistics industry in the US has been growing rapidly, supported by rising pharmaceutical output, increased use of biologic treatments, and tighter regulation on storage and distribution conditions. DHL’s investment aligns with this trend and reflects a larger corporate strategy to build scalable infrastructure for temperature‑sensitive and highly regulated supply chains.
The new facility sits alongside other recent investments by DHL in specialized logistics infrastructure, including acquisitions focused on final‑mile service and biomedical transport. These moves support the company’s broader Strategy 2030, which identifies life sciences and healthcare as key global growth areas.
Industry analysts note that advanced logistics capabilities, such as those offered by the Annville hub, are becoming essential for companies that must balance speed, compliance, safety and cost efficiency. Companies that can offer seamless, temperature‑controlled logistics with robust customs support and precise delivery are increasingly preferred partners for healthcare manufacturers and distributors.
Broader implications for healthcare supply chains
The new DHL hub comes at a time of rapid expansion in healthcare logistics demand, driven by factors including an aging population, growth in complex therapies, and increased reliance on regional distribution networks to support just‑in‑time delivery models. Facilities that combine cold chain expertise, advanced infrastructure and final‑mile capabilities help reduce lead times and support patient‑level care.
By integrating facility‑based distribution with local delivery services, DHL is positioning itself to serve the full spectrum of healthcare logistics needs, from large‑scale warehouse handling to precise, time‑sensitive patient delivery. This integrated network may offer customers greater consistency and reliability as they respond to fluctuations in demand, regulatory changes and competitive pressures.
Mark Kunar’s comments underscore the company’s intent to support the healthcare ecosystem holistically, with infrastructure that matches the pace of innovation in pharmaceuticals and medical technology. The combined network of specialized hubs and delivery services aims to deliver both efficiency and resilience to healthcare supply chains across the East Coast and beyond.
Sources